BRAINQORE Trademark

Trademark Overview

On Friday, January 4, 2019, a trademark application was filed for BRAINQORE with the United States Patent and Trademark Office. The USPTO has given the BRAINQORE trademark a serial number of 88249944. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, April 15, 2025. The BRAINQORE trademark is filed in the Advertising, Business and Retail Services category with the following description:

Business management consulting and advisory services for the pharmaceutical industry
brainqore

General Information

Serial Number88249944
Word MarkBRAINQORE
Filing DateFriday, January 4, 2019
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, April 15, 2025
Registration Number5939835
Registration DateTuesday, December 17, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 30, 2019

Trademark Statements

Pseudo MarkBRAIN CORE
Goods and ServicesBusiness management consulting and advisory services for the pharmaceutical industry

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateSaturday, January 26, 2019
Primary Code035
First Use Anywhere DateMonday, April 8, 2019
First Use In Commerce DateWednesday, April 17, 2019

Trademark Owner History

Party NameNOT AVAILABLE
Party Type30 - Original Registrant
Legal Entity Type01 - Individual
AddressBettwil, Aargau 5618
CH
Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressBettwil, Aargau 5618
CH
Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressBettwil, Aargau 5618
CH

Trademark Events

Event DateEvent Description
Tuesday, January 8, 2019NEW APPLICATION ENTERED
Saturday, January 26, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 22, 2019ASSIGNED TO EXAMINER
Friday, March 22, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 25, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, April 10, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 30, 2019PUBLISHED FOR OPPOSITION
Tuesday, April 30, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 8, 2019TEAS STATEMENT OF USE RECEIVED
Tuesday, October 8, 2019USE AMENDMENT FILED
Friday, November 15, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 8, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 8, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 25, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, October 25, 2019STATEMENT OF USE PROCESSING COMPLETE
Thursday, November 14, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, December 17, 2019REGISTERED-PRINCIPAL REGISTER
Monday, April 7, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, April 15, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, April 15, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Monday, December 23, 2024TEAS SECTION 8 & 15 RECEIVED
Tuesday, December 17, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

brainqore pharmaceutical industry services advisory management consulting business